Amrit Pharmaceuticals - India
Amrit Pharmaceuticals is an India-based sterile injectable manufacturer founded in 1979, producing ampoules, vials, and eye/ear drops for its own generic portfolio and on a contract manufacturing basis for other pharmaceutical companies, with FDA registration and cGMP certification.
- Company typePrivate
- Founded1979
- HeadquartersAurangabad (Chhatrapati Sambhajinagar), India
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Amrit Pharmaceuticals - India does
Amrit Pharmaceuticals is an India-based privately held pharmaceutical manufacturer founded in 1979 and headquartered in Aurangabad (Chhatrapati Sambhajinagar), Maharashtra. The company specializes in sterile injectable dosage forms, commonly referred to as parenterals, with a product portfolio that includes ampoules, vials, and eye/ear drops. Its operations also extend into veterinary products and specialized offerings such as Salmon Gonadotropin. The manufacturing facility operates under cGMP (Schedule M) certification and holds FDA registration, enabling the production of sterile injectables intended for both domestic distribution and international export.
The company operates a dual business model that combines proprietary generic product manufacturing with contract manufacturing services for other pharmaceutical companies. Under its own label, it manufactures and distributes generic sterile products, while its contract manufacturing arm offers loan license arrangements to both established pharmaceutical manufacturers and emerging startups. This two-track model allows Amrit to leverage its regulatory certifications and existing production capacity across a broader range of clients without proportionally increasing its fixed cost base. The contract manufacturing offering covers ampoules, vials, and eye/ear drops, with associated quality control testing services.
Amrit Pharmaceuticals serves a B2B customer base consisting of pharmaceutical companies requiring sterile injectable manufacturing capacity, both domestically within India and in international markets via direct export. The company's value proposition rests on its FDA registration and cGMP compliance, which together lower regulatory barriers for partner companies seeking qualified sterile manufacturing partners. With a workforce of approximately 8 employees per disclosed records, the company is structured as a lean, niche-focused manufacturing operation rather than a large-scale industrial pharmaceutical enterprise.
Amrit Pharmaceuticals - India firmographics
Firmographics- Name
- Amrit Pharmaceuticals - India
- Legal name
- Amrit Pharmaceuticals
- Website
- https://amritpharma.com
- Company type
- Private
- Founded year
- 1979
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Amrit Pharmaceuticals is an India-based sterile injectable manufacturer founded in 1979, producing ampoules, vials, and eye/ear drops for its own generic portfolio and on a contract manufacturing basis for other pharmaceutical companies, with FDA registration and cGMP certification.
- Ownership category
- akta.pro rank
Amrit Pharmaceuticals - India industry classification
Industry- Product category
- Sterile Injectable Pharmaceutical Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Sterile Injectable Generics (HLAIABAC)
- akta.pro secondary industries
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH), Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes) (IMALAEAB)
Keywords
Where Amrit Pharmaceuticals - India is headquartered
LocationHeadquarters
- HQ city
- Aurangabad (Chhatrapati Sambhajinagar)
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Amrit Pharmaceuticals - India business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure
Revenue model
- Contract Manufacturing Services: Provides contract aseptic manufacturing services to pharmaceutical companies, from clinical stage manufacturing through scale-up to full commercial production. Services include manufacturing, quality control, and packaging for vials, ampoules, and sterile injectables.
- Generic Products Sales: Growth through own generic products complementing contract manufacturing operations. The company develops and sells its own generic pharmaceutical products alongside manufacturing for other companies.
Go-to-market motion1 record
Distribution channels3 records
Amrit Pharmaceuticals - India product offering
Product offeringCore offering
Amrit Pharmaceuticals manufactures and contract-manufactures sterile injectable pharmaceutical products (parenterals), including human and veterinary injections in ampoules (1ml–10ml) and vials (2ml, 3ml, 10ml), plus eye and ear drops. The company also provides aseptic contract manufacturing services, analytical and bioanalytical testing, and packaging services for pharmaceutical companies across domestic and international markets.
Product overview
Amrit Pharmaceuticals is a cGMP-certified pharmaceutical manufacturer since 1979, specializing in sterile parenteral products. The company operates as both a product manufacturer and contract manufacturing service provider. Core products include human and veterinary injections (ampoules and vials), eye/ear drops, and specialized formulations like Salmon Gonadotropin Releasing Hormone and Alpha-Beta Arteether Injection. Contract services encompass aseptic manufacturing, comprehensive quality control and analytical testing, and packaging (primary blister packaging and secondary packaging). The company serves both domestic and international markets through direct export, loan license, and local market distribution.
Differentiator
Problem solved
Functional benefit
Products and services
- Human Injections (Ampoules and Vials) Sterile injectable pharmaceutical products for human use, manufactured in a cGMP-certified facility, available in ampoules (1ml, 2ml, 3ml, 5ml, 10ml) and vials (2ml, 3ml, 10ml). Sold through direct distribution and contract manufacturing channels.
- Veterinary Injections Sterile injectable pharmaceutical products for veterinary use, including specialized formulations, manufactured in cGMP-certified facility.
- Eye and Ear Drops
Companies that use Amrit Pharmaceuticals - India
Customer profileSegments2 records
Ideal customer profiles2 records
Amrit Pharmaceuticals - India technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Amrit Pharmaceuticals - India partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights4 records
Amrit Pharmaceuticals - India competitors and assessment
Company assessmentDirect peers
- Nitin Lifesciences: Indian manufacturer focused on veterinary and human sterile injectables in ampoule and vial formats. Comparable niche specialization in injectable formulations and export orientation.
- Krebs Biochemicals & Industries: Indian manufacturer of sterile injectables and active pharmaceutical ingredients with contract manufacturing services. Comparable in scale and product mix including ampoules and vials.
- Lincoln Pharmaceuticals: Gujarat-based manufacturer of sterile injectable formulations including ampoules, vials, and specialized dosage forms for human and veterinary use. Overlapping product portfolio and contract manufacturing capabilities.
- Sentiss Pharma: India-based sterile injectable manufacturer with focus on ampoules, vials, and ophthalmic products for global markets. Directly comparable CDMO/own-generic mix serving regulated and semi-regulated markets.
- Bharat Parenterals: Indian manufacturer of sterile parenteral preparations including small-volume injectables in ampoules and vials. Comparable product range, regulatory positioning, and contract manufacturing orientation.
- Akums Drugs & Pharmaceuticals: One of India's largest contract manufacturers of sterile injectables, ampoules, vials, and ophthalmic formulations. Closely comparable to Amrit's core CDMO offering across dosage forms and regulatory standing, though at significantly larger scale.
- Scott-Edil Advance Research Labs: India-based sterile injectables manufacturer with ampoule and vial capabilities serving domestic and international markets. Comparable product orientation and customer segments.
Broad incumbents
- Piramal Pharma Solutions: Large diversified CDMO offering sterile injectable manufacturing among many other services. Operates at significantly greater scale with broader regulatory clearances but overlaps with Amrit's parenteral contract manufacturing niche.
- Strides Pharma Science: Indian pharma company with significant sterile injectables business including ampoules, vials, and prefilled syringes across global regulated markets. Overlaps with Amrit's sterile injectable offering but with much larger commercial and regulatory footprint.
Regional players
- Century Pharmaceuticals: India-based sterile injectables manufacturer with ampoule, vial, and lyophilized capabilities serving domestic and emerging markets. Comparable in scale and product range, focused primarily on Indian/regional markets.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Amrit Pharmaceuticals - India social profiles
Digital presenceAmrit Pharmaceuticals - India compliance and trust
Trust signalCompliance2 records
Amrit Pharmaceuticals - India financial estimates
Financial estimateRevenue estimate
Valuation estimate
Amrit Pharmaceuticals - India leadership team
Management profileNumber of profiles
Amrit Pharmaceuticals - India funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Amrit Pharmaceuticals - India M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Amrit Pharmaceuticals - India
What does Amrit Pharmaceuticals - India do?
Amrit Pharmaceuticals manufactures and contract-manufactures sterile injectable pharmaceutical products (parenterals), including human and veterinary injections in ampoules (1ml–10ml) and vials (2ml, 3ml, 10ml), plus eye and ear drops. The company also provides aseptic contract manufacturing services, analytical and bioanalytical testing, and packaging services for pharmaceutical companies across domestic and international markets.
Is Amrit Pharmaceuticals - India a public or private company?
Amrit Pharmaceuticals - India is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Amrit Pharmaceuticals - India founded?
Amrit Pharmaceuticals - India was founded in 1979. It employs 1 to 10 people.
Where is Amrit Pharmaceuticals - India based?
Amrit Pharmaceuticals - India is headquartered in Aurangabad (Chhatrapati Sambhajinagar), India, in the Asia region.
How does Amrit Pharmaceuticals - India make money?
Two revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are generic Products Sales.
Who are Amrit Pharmaceuticals - India's main competitors?
Direct peers on record are Nitin Lifesciences, Krebs Biochemicals & Industries, Lincoln Pharmaceuticals, Sentiss Pharma, Bharat Parenterals, Akums Drugs & Pharmaceuticals and Scott-Edil Advance Research Labs. Broad incumbents are Piramal Pharma Solutions and Strides Pharma Science. Century Pharmaceuticals is listed as a regional player.
Does Amrit Pharmaceuticals - India have an API?
No public API is recorded for Amrit Pharmaceuticals - India.
What industry is Amrit Pharmaceuticals - India in?
Amrit Pharmaceuticals - India's product category is Sterile Injectable Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAIABAC, Sterile Injectable Generics, with a secondary code of HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing. Its NAICS code is 325412 and its SIC code is 2834.